nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB5—coronary artery disease	0.506	1	CbGaD
Carfilzomib—ABCB1—Ticagrelor—coronary artery disease	0.0278	0.13	CbGbCtD
Carfilzomib—ABCB1—Perindopril—coronary artery disease	0.0172	0.0806	CbGbCtD
Carfilzomib—ABCB1—Clopidogrel—coronary artery disease	0.0172	0.0806	CbGbCtD
Carfilzomib—ABCB1—Telmisartan—coronary artery disease	0.015	0.0704	CbGbCtD
Carfilzomib—ABCB1—Pitavastatin—coronary artery disease	0.015	0.0704	CbGbCtD
Carfilzomib—ABCB1—Enalapril—coronary artery disease	0.0142	0.0667	CbGbCtD
Carfilzomib—ABCB1—Lisinopril—coronary artery disease	0.0142	0.0667	CbGbCtD
Carfilzomib—ABCB1—Timolol—coronary artery disease	0.0121	0.0568	CbGbCtD
Carfilzomib—ABCB1—Ezetimibe—coronary artery disease	0.0111	0.0519	CbGbCtD
Carfilzomib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0108	0.0506	CbGbCtD
Carfilzomib—ABCB1—Captopril—coronary artery disease	0.0107	0.05	CbGbCtD
Carfilzomib—ABCB1—Simvastatin—coronary artery disease	0.0103	0.0483	CbGbCtD
Carfilzomib—ABCB1—Pravastatin—coronary artery disease	0.0101	0.0472	CbGbCtD
Carfilzomib—ABCB1—Lovastatin—coronary artery disease	0.0101	0.0472	CbGbCtD
Carfilzomib—ABCB1—Atorvastatin—coronary artery disease	0.00918	0.043	CbGbCtD
Carfilzomib—ABCB1—Losartan—coronary artery disease	0.0084	0.0393	CbGbCtD
Carfilzomib—PSMB10—heart—coronary artery disease	0.00237	0.0792	CbGeAlD
Carfilzomib—PSMB5—cardiac ventricle—coronary artery disease	0.00205	0.0687	CbGeAlD
Carfilzomib—PSMB5—myocardium—coronary artery disease	0.00193	0.0646	CbGeAlD
Carfilzomib—PSMB1—cardiac ventricle—coronary artery disease	0.00179	0.06	CbGeAlD
Carfilzomib—PSMB10—blood—coronary artery disease	0.00177	0.0591	CbGeAlD
Carfilzomib—PSMB2—cardiac ventricle—coronary artery disease	0.00175	0.0586	CbGeAlD
Carfilzomib—PSMB1—myocardium—coronary artery disease	0.00169	0.0565	CbGeAlD
Carfilzomib—PSMB2—myocardium—coronary artery disease	0.00165	0.0551	CbGeAlD
Carfilzomib—PSMB8—heart—coronary artery disease	0.00153	0.051	CbGeAlD
Carfilzomib—PSMB5—heart—coronary artery disease	0.00135	0.0451	CbGeAlD
Carfilzomib—PSMB1—heart—coronary artery disease	0.00118	0.0394	CbGeAlD
Carfilzomib—PSMB5—cardiac atrium—coronary artery disease	0.00115	0.0386	CbGeAlD
Carfilzomib—PSMB2—heart—coronary artery disease	0.00115	0.0385	CbGeAlD
Carfilzomib—PSMB8—blood—coronary artery disease	0.00114	0.0381	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—coronary artery disease	0.00111	0.0372	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—coronary artery disease	0.00108	0.0363	CbGeAlD
Carfilzomib—PSMB1—cardiac atrium—coronary artery disease	0.00101	0.0337	CbGeAlD
Carfilzomib—PSMB5—blood—coronary artery disease	0.00101	0.0336	CbGeAlD
Carfilzomib—PSMB2—cardiac atrium—coronary artery disease	0.000983	0.0329	CbGeAlD
Carfilzomib—PSMB1—blood—coronary artery disease	0.000879	0.0294	CbGeAlD
Carfilzomib—PSMB2—blood—coronary artery disease	0.000858	0.0287	CbGeAlD
Carfilzomib—PSMB8—Fluvastatin—Pitavastatin—coronary artery disease	0.000835	0.34	CbGdCrCtD
Carfilzomib—PSMB8—Fluvastatin—Rosuvastatin—coronary artery disease	0.000745	0.303	CbGdCrCtD
Carfilzomib—PSMB8—Fluvastatin—Atorvastatin—coronary artery disease	0.000633	0.257	CbGdCrCtD
Carfilzomib—Lopinavir—CYP2C19—coronary artery disease	0.000335	0.543	CrCbGaD
Carfilzomib—Ritonavir—CYP2C19—coronary artery disease	0.000282	0.457	CrCbGaD
Carfilzomib—PSMB8—Testosterone Propionate—Eplerenone—coronary artery disease	0.000247	0.1	CbGdCrCtD
Carfilzomib—ABCB1—heart—coronary artery disease	0.000176	0.00587	CbGeAlD
Carfilzomib—ABCB1—cardiovascular system—coronary artery disease	0.000166	0.00554	CbGeAlD
Carfilzomib—ABCB1—blood—coronary artery disease	0.000131	0.00438	CbGeAlD
Carfilzomib—Thrombocytopenia—Captopril—coronary artery disease	0.00011	0.001	CcSEcCtD
Carfilzomib—Decreased appetite—Valsartan—coronary artery disease	0.00011	0.001	CcSEcCtD
Carfilzomib—Dyspnoea—Niacin—coronary artery disease	0.000109	0.001	CcSEcCtD
Carfilzomib—Insomnia—Pravastatin—coronary artery disease	0.000109	0.001	CcSEcCtD
Carfilzomib—Decreased appetite—Olmesartan—coronary artery disease	0.000109	0.000999	CcSEcCtD
Carfilzomib—Cough—Losartan—coronary artery disease	0.000109	0.000999	CcSEcCtD
Carfilzomib—Fatigue—Valsartan—coronary artery disease	0.000109	0.000996	CcSEcCtD
Carfilzomib—Body temperature increased—Eplerenone—coronary artery disease	0.000108	0.000992	CcSEcCtD
Carfilzomib—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000108	0.000991	CcSEcCtD
Carfilzomib—Fatigue—Olmesartan—coronary artery disease	0.000108	0.000991	CcSEcCtD
Carfilzomib—Constipation—Valsartan—coronary artery disease	0.000108	0.000988	CcSEcCtD
Carfilzomib—Dyspnoea—Pravastatin—coronary artery disease	0.000108	0.000986	CcSEcCtD
Carfilzomib—Pain—Olmesartan—coronary artery disease	0.000107	0.000983	CcSEcCtD
Carfilzomib—Constipation—Olmesartan—coronary artery disease	0.000107	0.000983	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000107	0.000978	CcSEcCtD
Carfilzomib—Anorexia—Captopril—coronary artery disease	0.000107	0.000978	CcSEcCtD
Carfilzomib—Decreased appetite—Niacin—coronary artery disease	0.000107	0.000976	CcSEcCtD
Carfilzomib—Thrombocytopenia—Perindopril—coronary artery disease	0.000106	0.000975	CcSEcCtD
Carfilzomib—Arthralgia—Losartan—coronary artery disease	0.000106	0.000974	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000106	0.000974	CcSEcCtD
Carfilzomib—Insomnia—Trandolapril—coronary artery disease	0.000106	0.000971	CcSEcCtD
Carfilzomib—Insomnia—Enalapril—coronary artery disease	0.000106	0.000967	CcSEcCtD
Carfilzomib—Body temperature increased—Simvastatin—coronary artery disease	0.000106	0.000967	CcSEcCtD
Carfilzomib—Headache—Rosuvastatin—coronary artery disease	0.000106	0.000967	CcSEcCtD
Carfilzomib—Decreased appetite—Pravastatin—coronary artery disease	0.000105	0.000961	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000105	0.000961	CcSEcCtD
Carfilzomib—Asthenia—Fenofibrate—coronary artery disease	0.000105	0.000961	CcSEcCtD
Carfilzomib—Pain—Niacin—coronary artery disease	0.000105	0.00096	CcSEcCtD
Carfilzomib—Dyspnoea—Trandolapril—coronary artery disease	0.000105	0.000957	CcSEcCtD
Carfilzomib—Insomnia—Telmisartan—coronary artery disease	0.000104	0.000954	CcSEcCtD
Carfilzomib—Dyspnoea—Enalapril—coronary artery disease	0.000104	0.000953	CcSEcCtD
Carfilzomib—Fatigue—Pravastatin—coronary artery disease	0.000104	0.000953	CcSEcCtD
Carfilzomib—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000104	0.000953	CcSEcCtD
Carfilzomib—Anorexia—Perindopril—coronary artery disease	0.000104	0.000949	CcSEcCtD
Carfilzomib—Thrombocytopenia—Furosemide—coronary artery disease	0.000103	0.000948	CcSEcCtD
Carfilzomib—Pain—Pravastatin—coronary artery disease	0.000103	0.000946	CcSEcCtD
Carfilzomib—Constipation—Pravastatin—coronary artery disease	0.000103	0.000946	CcSEcCtD
Carfilzomib—Asthenia—Clopidogrel—coronary artery disease	0.000103	0.000944	CcSEcCtD
Carfilzomib—Muscle spasms—Ramipril—coronary artery disease	0.000103	0.000944	CcSEcCtD
Carfilzomib—Dyspnoea—Telmisartan—coronary artery disease	0.000103	0.00094	CcSEcCtD
Carfilzomib—Asthenia—Lovastatin—coronary artery disease	0.000102	0.000938	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000102	0.000934	CcSEcCtD
Carfilzomib—Decreased appetite—Trandolapril—coronary artery disease	0.000102	0.000933	CcSEcCtD
Carfilzomib—Decreased appetite—Enalapril—coronary artery disease	0.000101	0.00093	CcSEcCtD
Carfilzomib—Infection—Losartan—coronary artery disease	0.000101	0.000928	CcSEcCtD
Carfilzomib—Insomnia—Captopril—coronary artery disease	0.000101	0.000928	CcSEcCtD
Carfilzomib—Fatigue—Trandolapril—coronary artery disease	0.000101	0.000926	CcSEcCtD
Carfilzomib—Anorexia—Furosemide—coronary artery disease	0.000101	0.000923	CcSEcCtD
Carfilzomib—Fatigue—Enalapril—coronary artery disease	0.000101	0.000922	CcSEcCtD
Carfilzomib—Asthenia—Ezetimibe—coronary artery disease	0.0001	0.00092	CcSEcCtD
Carfilzomib—Constipation—Trandolapril—coronary artery disease	0.0001	0.000918	CcSEcCtD
Carfilzomib—Chills—Lisinopril—coronary artery disease	0.0001	0.000917	CcSEcCtD
Carfilzomib—Decreased appetite—Telmisartan—coronary artery disease	0.0001	0.000917	CcSEcCtD
Carfilzomib—Nausea—Rosuvastatin—coronary artery disease	0.0001	0.000916	CcSEcCtD
Carfilzomib—Diarrhoea—Fenofibrate—coronary artery disease	0.0001	0.000916	CcSEcCtD
Carfilzomib—Thrombocytopenia—Losartan—coronary artery disease	9.98e-05	0.000915	CcSEcCtD
Carfilzomib—Constipation—Enalapril—coronary artery disease	9.98e-05	0.000915	CcSEcCtD
Carfilzomib—Dyspnoea—Captopril—coronary artery disease	9.98e-05	0.000914	CcSEcCtD
Carfilzomib—Fatigue—Telmisartan—coronary artery disease	9.93e-05	0.000909	CcSEcCtD
Carfilzomib—Body temperature increased—Olmesartan—coronary artery disease	9.92e-05	0.000909	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Perindopril—coronary artery disease	9.91e-05	0.000907	CcSEcCtD
Carfilzomib—Pain—Telmisartan—coronary artery disease	9.85e-05	0.000902	CcSEcCtD
Carfilzomib—Constipation—Telmisartan—coronary artery disease	9.85e-05	0.000902	CcSEcCtD
Carfilzomib—Insomnia—Perindopril—coronary artery disease	9.83e-05	0.000901	CcSEcCtD
Carfilzomib—Diarrhoea—Clopidogrel—coronary artery disease	9.83e-05	0.000901	CcSEcCtD
Carfilzomib—Asthenia—Eplerenone—coronary artery disease	9.83e-05	0.000901	CcSEcCtD
Carfilzomib—Diarrhoea—Lovastatin—coronary artery disease	9.77e-05	0.000895	CcSEcCtD
Carfilzomib—Decreased appetite—Captopril—coronary artery disease	9.73e-05	0.000892	CcSEcCtD
Carfilzomib—Anorexia—Losartan—coronary artery disease	9.72e-05	0.00089	CcSEcCtD
Carfilzomib—Nausea—Acetylsalicylic acid—coronary artery disease	9.72e-05	0.00089	CcSEcCtD
Carfilzomib—Dyspnoea—Perindopril—coronary artery disease	9.69e-05	0.000888	CcSEcCtD
Carfilzomib—Body temperature increased—Niacin—coronary artery disease	9.69e-05	0.000888	CcSEcCtD
Carfilzomib—Dizziness—Fenofibrate—coronary artery disease	9.67e-05	0.000885	CcSEcCtD
Carfilzomib—Fatigue—Captopril—coronary artery disease	9.65e-05	0.000884	CcSEcCtD
Carfilzomib—Leukopenia—Ramipril—coronary artery disease	9.59e-05	0.000878	CcSEcCtD
Carfilzomib—Asthenia—Simvastatin—coronary artery disease	9.58e-05	0.000877	CcSEcCtD
Carfilzomib—Diarrhoea—Ezetimibe—coronary artery disease	9.58e-05	0.000877	CcSEcCtD
Carfilzomib—Constipation—Captopril—coronary artery disease	9.58e-05	0.000877	CcSEcCtD
Carfilzomib—Body temperature increased—Pravastatin—coronary artery disease	9.54e-05	0.000874	CcSEcCtD
Carfilzomib—Dizziness—Clopidogrel—coronary artery disease	9.5e-05	0.00087	CcSEcCtD
Carfilzomib—Decreased appetite—Perindopril—coronary artery disease	9.45e-05	0.000866	CcSEcCtD
Carfilzomib—Dizziness—Lovastatin—coronary artery disease	9.44e-05	0.000865	CcSEcCtD
Carfilzomib—Back pain—Lisinopril—coronary artery disease	9.4e-05	0.000861	CcSEcCtD
Carfilzomib—Diarrhoea—Eplerenone—coronary artery disease	9.38e-05	0.000859	CcSEcCtD
Carfilzomib—Fatigue—Perindopril—coronary artery disease	9.37e-05	0.000859	CcSEcCtD
Carfilzomib—Cough—Ramipril—coronary artery disease	9.35e-05	0.000856	CcSEcCtD
Carfilzomib—Muscle spasms—Lisinopril—coronary artery disease	9.34e-05	0.000856	CcSEcCtD
Carfilzomib—Pain—Perindopril—coronary artery disease	9.3e-05	0.000852	CcSEcCtD
Carfilzomib—Constipation—Perindopril—coronary artery disease	9.3e-05	0.000852	CcSEcCtD
Carfilzomib—Vomiting—Fenofibrate—coronary artery disease	9.29e-05	0.000851	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Losartan—coronary artery disease	9.29e-05	0.000851	CcSEcCtD
Carfilzomib—Body temperature increased—Trandolapril—coronary artery disease	9.27e-05	0.000849	CcSEcCtD
Carfilzomib—Dizziness—Ezetimibe—coronary artery disease	9.26e-05	0.000848	CcSEcCtD
Carfilzomib—Body temperature increased—Enalapril—coronary artery disease	9.23e-05	0.000845	CcSEcCtD
Carfilzomib—Insomnia—Losartan—coronary artery disease	9.22e-05	0.000845	CcSEcCtD
Carfilzomib—Decreased appetite—Furosemide—coronary artery disease	9.19e-05	0.000842	CcSEcCtD
Carfilzomib—Headache—Fenofibrate—coronary artery disease	9.16e-05	0.000839	CcSEcCtD
Carfilzomib—Cough—Timolol—coronary artery disease	9.14e-05	0.000837	CcSEcCtD
Carfilzomib—Vomiting—Clopidogrel—coronary artery disease	9.14e-05	0.000837	CcSEcCtD
Carfilzomib—Diarrhoea—Simvastatin—coronary artery disease	9.14e-05	0.000837	CcSEcCtD
Carfilzomib—Arthralgia—Ramipril—coronary artery disease	9.12e-05	0.000836	CcSEcCtD
Carfilzomib—Fatigue—Furosemide—coronary artery disease	9.11e-05	0.000835	CcSEcCtD
Carfilzomib—Body temperature increased—Telmisartan—coronary artery disease	9.1e-05	0.000834	CcSEcCtD
Carfilzomib—Dyspnoea—Losartan—coronary artery disease	9.09e-05	0.000833	CcSEcCtD
Carfilzomib—Vomiting—Lovastatin—coronary artery disease	9.08e-05	0.000831	CcSEcCtD
Carfilzomib—Dizziness—Eplerenone—coronary artery disease	9.06e-05	0.00083	CcSEcCtD
Carfilzomib—Asthenia—Valsartan—coronary artery disease	9.05e-05	0.000829	CcSEcCtD
Carfilzomib—Hypertension—Timolol—coronary artery disease	9.04e-05	0.000828	CcSEcCtD
Carfilzomib—Constipation—Furosemide—coronary artery disease	9.04e-05	0.000828	CcSEcCtD
Carfilzomib—Pain—Furosemide—coronary artery disease	9.04e-05	0.000828	CcSEcCtD
Carfilzomib—Asthenia—Olmesartan—coronary artery disease	9e-05	0.000825	CcSEcCtD
Carfilzomib—Headache—Clopidogrel—coronary artery disease	9e-05	0.000825	CcSEcCtD
Carfilzomib—Anaemia—Lisinopril—coronary artery disease	8.98e-05	0.000823	CcSEcCtD
Carfilzomib—Headache—Lovastatin—coronary artery disease	8.94e-05	0.000819	CcSEcCtD
Carfilzomib—Arthralgia—Timolol—coronary artery disease	8.92e-05	0.000817	CcSEcCtD
Carfilzomib—Vomiting—Ezetimibe—coronary artery disease	8.9e-05	0.000815	CcSEcCtD
Carfilzomib—Decreased appetite—Losartan—coronary artery disease	8.86e-05	0.000812	CcSEcCtD
Carfilzomib—Body temperature increased—Captopril—coronary artery disease	8.85e-05	0.000811	CcSEcCtD
Carfilzomib—Dizziness—Simvastatin—coronary artery disease	8.83e-05	0.000809	CcSEcCtD
Carfilzomib—Asthenia—Niacin—coronary artery disease	8.8e-05	0.000806	CcSEcCtD
Carfilzomib—Fatigue—Losartan—coronary artery disease	8.79e-05	0.000805	CcSEcCtD
Carfilzomib—Headache—Ezetimibe—coronary artery disease	8.77e-05	0.000803	CcSEcCtD
Carfilzomib—Pain—Losartan—coronary artery disease	8.72e-05	0.000799	CcSEcCtD
Carfilzomib—Constipation—Losartan—coronary artery disease	8.72e-05	0.000799	CcSEcCtD
Carfilzomib—Vomiting—Eplerenone—coronary artery disease	8.71e-05	0.000798	CcSEcCtD
Carfilzomib—Leukopenia—Lisinopril—coronary artery disease	8.7e-05	0.000797	CcSEcCtD
Carfilzomib—Nausea—Fenofibrate—coronary artery disease	8.68e-05	0.000795	CcSEcCtD
Carfilzomib—Asthenia—Pravastatin—coronary artery disease	8.66e-05	0.000793	CcSEcCtD
Carfilzomib—Diarrhoea—Valsartan—coronary artery disease	8.63e-05	0.00079	CcSEcCtD
Carfilzomib—Body temperature increased—Perindopril—coronary artery disease	8.59e-05	0.000787	CcSEcCtD
Carfilzomib—Diarrhoea—Olmesartan—coronary artery disease	8.59e-05	0.000786	CcSEcCtD
Carfilzomib—Headache—Eplerenone—coronary artery disease	8.58e-05	0.000786	CcSEcCtD
Carfilzomib—Thrombocytopenia—Ramipril—coronary artery disease	8.56e-05	0.000784	CcSEcCtD
Carfilzomib—Nausea—Clopidogrel—coronary artery disease	8.54e-05	0.000782	CcSEcCtD
Carfilzomib—Infection—Timolol—coronary artery disease	8.49e-05	0.000778	CcSEcCtD
Carfilzomib—Vomiting—Simvastatin—coronary artery disease	8.49e-05	0.000778	CcSEcCtD
Carfilzomib—Cough—Lisinopril—coronary artery disease	8.48e-05	0.000777	CcSEcCtD
Carfilzomib—Nausea—Lovastatin—coronary artery disease	8.48e-05	0.000777	CcSEcCtD
Carfilzomib—Asthenia—Trandolapril—coronary artery disease	8.41e-05	0.00077	CcSEcCtD
Carfilzomib—Diarrhoea—Niacin—coronary artery disease	8.39e-05	0.000768	CcSEcCtD
Carfilzomib—Asthenia—Enalapril—coronary artery disease	8.38e-05	0.000767	CcSEcCtD
Carfilzomib—Headache—Simvastatin—coronary artery disease	8.36e-05	0.000766	CcSEcCtD
Carfilzomib—Body temperature increased—Furosemide—coronary artery disease	8.35e-05	0.000765	CcSEcCtD
Carfilzomib—Dizziness—Valsartan—coronary artery disease	8.34e-05	0.000764	CcSEcCtD
Carfilzomib—Anorexia—Ramipril—coronary artery disease	8.33e-05	0.000763	CcSEcCtD
Carfilzomib—Nausea—Ezetimibe—coronary artery disease	8.32e-05	0.000762	CcSEcCtD
Carfilzomib—Dizziness—Olmesartan—coronary artery disease	8.3e-05	0.00076	CcSEcCtD
Carfilzomib—Arthralgia—Lisinopril—coronary artery disease	8.27e-05	0.000758	CcSEcCtD
Carfilzomib—Asthenia—Telmisartan—coronary artery disease	8.26e-05	0.000757	CcSEcCtD
Carfilzomib—Diarrhoea—Pravastatin—coronary artery disease	8.26e-05	0.000757	CcSEcCtD
Carfilzomib—Anorexia—Timolol—coronary artery disease	8.15e-05	0.000746	CcSEcCtD
Carfilzomib—Nausea—Eplerenone—coronary artery disease	8.14e-05	0.000746	CcSEcCtD
Carfilzomib—Dizziness—Niacin—coronary artery disease	8.11e-05	0.000743	CcSEcCtD
Carfilzomib—Body temperature increased—Losartan—coronary artery disease	8.06e-05	0.000738	CcSEcCtD
Carfilzomib—Asthenia—Captopril—coronary artery disease	8.03e-05	0.000736	CcSEcCtD
Carfilzomib—Diarrhoea—Trandolapril—coronary artery disease	8.02e-05	0.000735	CcSEcCtD
Carfilzomib—Vomiting—Valsartan—coronary artery disease	8.02e-05	0.000734	CcSEcCtD
Carfilzomib—Diarrhoea—Enalapril—coronary artery disease	7.99e-05	0.000732	CcSEcCtD
Carfilzomib—Dizziness—Pravastatin—coronary artery disease	7.98e-05	0.000731	CcSEcCtD
Carfilzomib—Vomiting—Olmesartan—coronary artery disease	7.98e-05	0.000731	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Ramipril—coronary artery disease	7.97e-05	0.00073	CcSEcCtD
Carfilzomib—Nausea—Simvastatin—coronary artery disease	7.93e-05	0.000726	CcSEcCtD
Carfilzomib—Insomnia—Ramipril—coronary artery disease	7.91e-05	0.000724	CcSEcCtD
Carfilzomib—Headache—Valsartan—coronary artery disease	7.9e-05	0.000724	CcSEcCtD
Carfilzomib—Diarrhoea—Telmisartan—coronary artery disease	7.88e-05	0.000722	CcSEcCtD
Carfilzomib—Infection—Lisinopril—coronary artery disease	7.88e-05	0.000722	CcSEcCtD
Carfilzomib—Headache—Olmesartan—coronary artery disease	7.86e-05	0.00072	CcSEcCtD
Carfilzomib—Asthenia—Perindopril—coronary artery disease	7.8e-05	0.000715	CcSEcCtD
Carfilzomib—Dyspnoea—Ramipril—coronary artery disease	7.8e-05	0.000714	CcSEcCtD
Carfilzomib—Vomiting—Niacin—coronary artery disease	7.79e-05	0.000714	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Timolol—coronary artery disease	7.79e-05	0.000713	CcSEcCtD
Carfilzomib—Thrombocytopenia—Lisinopril—coronary artery disease	7.76e-05	0.000711	CcSEcCtD
Carfilzomib—Dizziness—Trandolapril—coronary artery disease	7.75e-05	0.00071	CcSEcCtD
Carfilzomib—Insomnia—Timolol—coronary artery disease	7.73e-05	0.000708	CcSEcCtD
Carfilzomib—Dizziness—Enalapril—coronary artery disease	7.72e-05	0.000707	CcSEcCtD
Carfilzomib—Headache—Niacin—coronary artery disease	7.68e-05	0.000704	CcSEcCtD
Carfilzomib—Vomiting—Pravastatin—coronary artery disease	7.67e-05	0.000703	CcSEcCtD
Carfilzomib—Diarrhoea—Captopril—coronary artery disease	7.66e-05	0.000702	CcSEcCtD
Carfilzomib—Dyspnoea—Timolol—coronary artery disease	7.62e-05	0.000698	CcSEcCtD
Carfilzomib—Dizziness—Telmisartan—coronary artery disease	7.61e-05	0.000698	CcSEcCtD
Carfilzomib—Decreased appetite—Ramipril—coronary artery disease	7.6e-05	0.000696	CcSEcCtD
Carfilzomib—Asthenia—Furosemide—coronary artery disease	7.58e-05	0.000695	CcSEcCtD
Carfilzomib—Headache—Pravastatin—coronary artery disease	7.56e-05	0.000693	CcSEcCtD
Carfilzomib—Anorexia—Lisinopril—coronary artery disease	7.56e-05	0.000692	CcSEcCtD
Carfilzomib—Fatigue—Ramipril—coronary artery disease	7.54e-05	0.000691	CcSEcCtD
Carfilzomib—Nausea—Valsartan—coronary artery disease	7.49e-05	0.000686	CcSEcCtD
Carfilzomib—Constipation—Ramipril—coronary artery disease	7.48e-05	0.000685	CcSEcCtD
Carfilzomib—Nausea—Olmesartan—coronary artery disease	7.45e-05	0.000683	CcSEcCtD
Carfilzomib—Vomiting—Trandolapril—coronary artery disease	7.45e-05	0.000683	CcSEcCtD
Carfilzomib—Diarrhoea—Perindopril—coronary artery disease	7.44e-05	0.000681	CcSEcCtD
Carfilzomib—Decreased appetite—Timolol—coronary artery disease	7.43e-05	0.000681	CcSEcCtD
Carfilzomib—Vomiting—Enalapril—coronary artery disease	7.42e-05	0.00068	CcSEcCtD
Carfilzomib—Dizziness—Captopril—coronary artery disease	7.4e-05	0.000678	CcSEcCtD
Carfilzomib—Fatigue—Timolol—coronary artery disease	7.37e-05	0.000675	CcSEcCtD
Carfilzomib—Headache—Trandolapril—coronary artery disease	7.34e-05	0.000673	CcSEcCtD
Carfilzomib—Vomiting—Telmisartan—coronary artery disease	7.32e-05	0.000671	CcSEcCtD
Carfilzomib—Asthenia—Losartan—coronary artery disease	7.32e-05	0.00067	CcSEcCtD
Carfilzomib—Headache—Enalapril—coronary artery disease	7.31e-05	0.00067	CcSEcCtD
Carfilzomib—Pain—Timolol—coronary artery disease	7.31e-05	0.00067	CcSEcCtD
Carfilzomib—Nausea—Niacin—coronary artery disease	7.28e-05	0.000667	CcSEcCtD
Carfilzomib—Diarrhoea—Furosemide—coronary artery disease	7.23e-05	0.000662	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.22e-05	0.000662	CcSEcCtD
Carfilzomib—Headache—Telmisartan—coronary artery disease	7.21e-05	0.000661	CcSEcCtD
Carfilzomib—Dizziness—Perindopril—coronary artery disease	7.19e-05	0.000659	CcSEcCtD
Carfilzomib—Insomnia—Lisinopril—coronary artery disease	7.17e-05	0.000657	CcSEcCtD
Carfilzomib—Nausea—Pravastatin—coronary artery disease	7.17e-05	0.000657	CcSEcCtD
Carfilzomib—Vomiting—Captopril—coronary artery disease	7.12e-05	0.000652	CcSEcCtD
Carfilzomib—Dyspnoea—Lisinopril—coronary artery disease	7.07e-05	0.000648	CcSEcCtD
Carfilzomib—Headache—Captopril—coronary artery disease	7.01e-05	0.000643	CcSEcCtD
Carfilzomib—Dizziness—Furosemide—coronary artery disease	6.99e-05	0.00064	CcSEcCtD
Carfilzomib—Diarrhoea—Losartan—coronary artery disease	6.98e-05	0.000639	CcSEcCtD
Carfilzomib—Nausea—Trandolapril—coronary artery disease	6.96e-05	0.000638	CcSEcCtD
Carfilzomib—Nausea—Enalapril—coronary artery disease	6.93e-05	0.000635	CcSEcCtD
Carfilzomib—Vomiting—Perindopril—coronary artery disease	6.91e-05	0.000633	CcSEcCtD
Carfilzomib—Body temperature increased—Ramipril—coronary artery disease	6.91e-05	0.000633	CcSEcCtD
Carfilzomib—Decreased appetite—Lisinopril—coronary artery disease	6.89e-05	0.000631	CcSEcCtD
Carfilzomib—Nausea—Telmisartan—coronary artery disease	6.84e-05	0.000627	CcSEcCtD
Carfilzomib—Fatigue—Lisinopril—coronary artery disease	6.84e-05	0.000626	CcSEcCtD
Carfilzomib—Headache—Perindopril—coronary artery disease	6.81e-05	0.000624	CcSEcCtD
Carfilzomib—Constipation—Lisinopril—coronary artery disease	6.78e-05	0.000621	CcSEcCtD
Carfilzomib—Pain—Lisinopril—coronary artery disease	6.78e-05	0.000621	CcSEcCtD
Carfilzomib—Body temperature increased—Timolol—coronary artery disease	6.76e-05	0.000619	CcSEcCtD
Carfilzomib—Dizziness—Losartan—coronary artery disease	6.74e-05	0.000618	CcSEcCtD
Carfilzomib—Vomiting—Furosemide—coronary artery disease	6.72e-05	0.000616	CcSEcCtD
Carfilzomib—Nausea—Captopril—coronary artery disease	6.65e-05	0.000609	CcSEcCtD
Carfilzomib—Headache—Furosemide—coronary artery disease	6.62e-05	0.000606	CcSEcCtD
Carfilzomib—Vomiting—Losartan—coronary artery disease	6.48e-05	0.000594	CcSEcCtD
Carfilzomib—Nausea—Perindopril—coronary artery disease	6.46e-05	0.000592	CcSEcCtD
Carfilzomib—Headache—Losartan—coronary artery disease	6.39e-05	0.000585	CcSEcCtD
Carfilzomib—Nausea—Furosemide—coronary artery disease	6.28e-05	0.000575	CcSEcCtD
Carfilzomib—Asthenia—Ramipril—coronary artery disease	6.27e-05	0.000575	CcSEcCtD
Carfilzomib—Body temperature increased—Lisinopril—coronary artery disease	6.27e-05	0.000574	CcSEcCtD
Carfilzomib—Asthenia—Timolol—coronary artery disease	6.13e-05	0.000562	CcSEcCtD
Carfilzomib—Nausea—Losartan—coronary artery disease	6.06e-05	0.000555	CcSEcCtD
Carfilzomib—Diarrhoea—Ramipril—coronary artery disease	5.98e-05	0.000548	CcSEcCtD
Carfilzomib—Diarrhoea—Timolol—coronary artery disease	5.85e-05	0.000536	CcSEcCtD
Carfilzomib—Dizziness—Ramipril—coronary artery disease	5.78e-05	0.00053	CcSEcCtD
Carfilzomib—Asthenia—Lisinopril—coronary artery disease	5.69e-05	0.000521	CcSEcCtD
Carfilzomib—Dizziness—Timolol—coronary artery disease	5.65e-05	0.000518	CcSEcCtD
Carfilzomib—Vomiting—Ramipril—coronary artery disease	5.56e-05	0.000509	CcSEcCtD
Carfilzomib—Headache—Ramipril—coronary artery disease	5.48e-05	0.000502	CcSEcCtD
Carfilzomib—Vomiting—Timolol—coronary artery disease	5.44e-05	0.000498	CcSEcCtD
Carfilzomib—Diarrhoea—Lisinopril—coronary artery disease	5.43e-05	0.000497	CcSEcCtD
Carfilzomib—Headache—Timolol—coronary artery disease	5.36e-05	0.000491	CcSEcCtD
Carfilzomib—Dizziness—Lisinopril—coronary artery disease	5.24e-05	0.00048	CcSEcCtD
Carfilzomib—Nausea—Ramipril—coronary artery disease	5.19e-05	0.000476	CcSEcCtD
Carfilzomib—Nausea—Timolol—coronary artery disease	5.08e-05	0.000465	CcSEcCtD
Carfilzomib—Vomiting—Lisinopril—coronary artery disease	5.04e-05	0.000462	CcSEcCtD
Carfilzomib—Headache—Lisinopril—coronary artery disease	4.97e-05	0.000455	CcSEcCtD
Carfilzomib—Nausea—Lisinopril—coronary artery disease	4.71e-05	0.000431	CcSEcCtD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	2.52e-06	1.82e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKBIA—coronary artery disease	2.52e-06	1.82e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—MAPK1—coronary artery disease	2.51e-06	1.81e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—MAPK1—coronary artery disease	2.5e-06	1.8e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX2—coronary artery disease	2.49e-06	1.8e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA2—coronary artery disease	2.49e-06	1.8e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G2A—coronary artery disease	2.49e-06	1.8e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KIT—coronary artery disease	2.48e-06	1.79e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KIT—coronary artery disease	2.48e-06	1.79e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KIT—coronary artery disease	2.48e-06	1.79e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ABCG5—coronary artery disease	2.46e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX4—coronary artery disease	2.46e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SULT1A1—coronary artery disease	2.46e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HK1—coronary artery disease	2.46e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—coronary artery disease	2.46e-06	1.77e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—coronary artery disease	2.46e-06	1.77e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—coronary artery disease	2.46e-06	1.77e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KIT—coronary artery disease	2.44e-06	1.76e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HADHA—coronary artery disease	2.43e-06	1.75e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—coronary artery disease	2.43e-06	1.75e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—AKT1—coronary artery disease	2.41e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—AKT1—coronary artery disease	2.41e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—AKT1—coronary artery disease	2.41e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—coronary artery disease	2.41e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTA1—coronary artery disease	2.4e-06	1.73e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	2.4e-06	1.73e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—coronary artery disease	2.4e-06	1.73e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GSK3B—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GSK3B—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GSK3B—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPA—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—AKT1—coronary artery disease	2.38e-06	1.72e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PIK3CA—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CREB1—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CREB1—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CREB1—coronary artery disease	2.36e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PIK3CA—coronary artery disease	2.35e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GSK3B—coronary artery disease	2.34e-06	1.69e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—coronary artery disease	2.33e-06	1.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CREB1—coronary artery disease	2.33e-06	1.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—coronary artery disease	2.31e-06	1.67e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—coronary artery disease	2.31e-06	1.67e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—coronary artery disease	2.31e-06	1.67e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CASP3—coronary artery disease	2.3e-06	1.66e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLCB3—coronary artery disease	2.3e-06	1.66e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6R—coronary artery disease	2.3e-06	1.66e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6R—coronary artery disease	2.3e-06	1.66e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6R—coronary artery disease	2.3e-06	1.66e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CASP3—coronary artery disease	2.29e-06	1.65e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA5—coronary artery disease	2.28e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—coronary artery disease	2.28e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1—coronary artery disease	2.27e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1—coronary artery disease	2.27e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1—coronary artery disease	2.27e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6R—coronary artery disease	2.27e-06	1.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—coronary artery disease	2.25e-06	1.62e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—coronary artery disease	2.25e-06	1.62e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—coronary artery disease	2.25e-06	1.62e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCND1—coronary artery disease	2.24e-06	1.62e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1—coronary artery disease	2.24e-06	1.61e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—P4HB—coronary artery disease	2.23e-06	1.61e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCND1—coronary artery disease	2.23e-06	1.61e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—coronary artery disease	2.22e-06	1.6e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G1B—coronary artery disease	2.19e-06	1.58e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	2.19e-06	1.58e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PIK3CA—coronary artery disease	2.18e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—coronary artery disease	2.18e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PIK3CA—coronary artery disease	2.17e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—coronary artery disease	2.17e-06	1.56e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—coronary artery disease	2.15e-06	1.55e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—coronary artery disease	2.15e-06	1.55e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—coronary artery disease	2.15e-06	1.55e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—coronary artery disease	2.12e-06	1.53e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—coronary artery disease	2.09e-06	1.51e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF2—coronary artery disease	2.09e-06	1.5e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF2—coronary artery disease	2.09e-06	1.5e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF2—coronary artery disease	2.09e-06	1.5e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—coronary artery disease	2.08e-06	1.5e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—VCAN—coronary artery disease	2.07e-06	1.49e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MAPK1—coronary artery disease	2.06e-06	1.49e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MAPK1—coronary artery disease	2.06e-06	1.49e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MAPK1—coronary artery disease	2.06e-06	1.49e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—coronary artery disease	2.06e-06	1.48e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—coronary artery disease	2.06e-06	1.48e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—coronary artery disease	2.06e-06	1.48e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF2—coronary artery disease	2.06e-06	1.48e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDOA—coronary artery disease	2.05e-06	1.48e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.04e-06	1.47e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MAPK1—coronary artery disease	2.03e-06	1.47e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—coronary artery disease	2.03e-06	1.46e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—JAK2—coronary artery disease	2e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—JAK2—coronary artery disease	2e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—JAK2—coronary artery disease	2e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DCN—coronary artery disease	1.99e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—JAK2—coronary artery disease	1.97e-06	1.42e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—coronary artery disease	1.96e-06	1.41e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—coronary artery disease	1.95e-06	1.4e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—coronary artery disease	1.94e-06	1.4e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—coronary artery disease	1.94e-06	1.4e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—coronary artery disease	1.94e-06	1.4e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH2—coronary artery disease	1.94e-06	1.4e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—coronary artery disease	1.93e-06	1.39e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—AKT1—coronary artery disease	1.93e-06	1.39e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—coronary artery disease	1.92e-06	1.39e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—AKT1—coronary artery disease	1.92e-06	1.39e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AKT1—coronary artery disease	1.92e-06	1.38e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—coronary artery disease	1.91e-06	1.38e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AKT1—coronary artery disease	1.91e-06	1.38e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MAPK1—coronary artery disease	1.9e-06	1.37e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MAPK1—coronary artery disease	1.9e-06	1.37e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MAPK1—coronary artery disease	1.9e-06	1.37e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBA1—coronary artery disease	1.89e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PIK3C2A—coronary artery disease	1.89e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2C19—coronary artery disease	1.89e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LIPC—coronary artery disease	1.89e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MAPK1—coronary artery disease	1.88e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOC3—coronary artery disease	1.88e-06	1.35e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LDLR—coronary artery disease	1.87e-06	1.35e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—coronary artery disease	1.84e-06	1.33e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC9A1—coronary artery disease	1.84e-06	1.33e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PIK3CA—coronary artery disease	1.83e-06	1.32e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—coronary artery disease	1.82e-06	1.32e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—coronary artery disease	1.82e-06	1.32e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—coronary artery disease	1.82e-06	1.32e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCLC—coronary artery disease	1.82e-06	1.31e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CETP—coronary artery disease	1.82e-06	1.31e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PIK3CA—coronary artery disease	1.82e-06	1.31e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SDC1—coronary artery disease	1.8e-06	1.3e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—coronary artery disease	1.8e-06	1.3e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PIK3CA—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PIK3CA—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PIK3CA—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—coronary artery disease	1.79e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—AKT1—coronary artery disease	1.78e-06	1.29e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—AKT1—coronary artery disease	1.77e-06	1.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PIK3CA—coronary artery disease	1.76e-06	1.27e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK1—coronary artery disease	1.76e-06	1.27e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK1—coronary artery disease	1.75e-06	1.26e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.26e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.26e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.26e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CASP3—coronary artery disease	1.72e-06	1.24e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PSMA6—coronary artery disease	1.7e-06	1.23e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PSMB5—coronary artery disease	1.7e-06	1.23e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	1.23e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	1.23e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	1.23e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCND1—coronary artery disease	1.68e-06	1.21e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CTGF—coronary artery disease	1.66e-06	1.2e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PIK3CA—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PIK3CA—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PIK3CA—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMGCR—coronary artery disease	1.65e-06	1.19e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PIK3CA—coronary artery disease	1.63e-06	1.18e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—coronary artery disease	1.63e-06	1.17e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.62e-06	1.17e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—coronary artery disease	1.59e-06	1.14e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—coronary artery disease	1.59e-06	1.14e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—coronary artery disease	1.59e-06	1.14e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—coronary artery disease	1.56e-06	1.13e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PIK3CA—coronary artery disease	1.53e-06	1.1e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PIK3CA—coronary artery disease	1.52e-06	1.1e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLCB1—coronary artery disease	1.52e-06	1.09e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AKT1—coronary artery disease	1.49e-06	1.08e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AKT1—coronary artery disease	1.48e-06	1.07e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.07e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.07e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.07e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ABCA1—coronary artery disease	1.47e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—AKT1—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—AKT1—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—AKT1—coronary artery disease	1.46e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—coronary artery disease	1.46e-06	1.05e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AKT1—coronary artery disease	1.45e-06	1.05e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AKT1—coronary artery disease	1.45e-06	1.05e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AKT1—coronary artery disease	1.45e-06	1.05e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—coronary artery disease	1.44e-06	1.04e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—AKT1—coronary artery disease	1.44e-06	1.04e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AKT1—coronary artery disease	1.43e-06	1.03e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—coronary artery disease	1.42e-06	1.03e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT1—coronary artery disease	1.42e-06	1.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PIK3CA—coronary artery disease	1.38e-06	9.99e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PIK3CA—coronary artery disease	1.38e-06	9.99e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PIK3CA—coronary artery disease	1.38e-06	9.99e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PIK3CA—coronary artery disease	1.36e-06	9.85e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	9.81e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	9.81e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	9.81e-06	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—coronary artery disease	1.35e-06	9.76e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—AKT1—coronary artery disease	1.35e-06	9.74e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—AKT1—coronary artery disease	1.35e-06	9.74e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—AKT1—coronary artery disease	1.35e-06	9.74e-06	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—coronary artery disease	1.35e-06	9.71e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—coronary artery disease	1.34e-06	9.68e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	9.62e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	9.62e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	9.62e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—AKT1—coronary artery disease	1.33e-06	9.61e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK1—coronary artery disease	1.31e-06	9.49e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—coronary artery disease	1.28e-06	9.22e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	9.13e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—coronary artery disease	1.26e-06	9.09e-06	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AKT1—coronary artery disease	1.25e-06	9e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—coronary artery disease	1.24e-06	8.97e-06	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AKT1—coronary artery disease	1.24e-06	8.96e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOB—coronary artery disease	1.21e-06	8.71e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—coronary artery disease	1.17e-06	8.47e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	8.35e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	8.35e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	8.35e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPL—coronary artery disease	1.15e-06	8.32e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-06	8.23e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AKT1—coronary artery disease	1.13e-06	8.16e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AKT1—coronary artery disease	1.13e-06	8.16e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AKT1—coronary artery disease	1.13e-06	8.16e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—coronary artery disease	1.12e-06	8.11e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AKT1—coronary artery disease	1.11e-06	8.04e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CD36—coronary artery disease	1.09e-06	7.9e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.08e-06	7.8e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—coronary artery disease	1.04e-06	7.49e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—coronary artery disease	1.02e-06	7.4e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—coronary artery disease	1.02e-06	7.4e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—coronary artery disease	1.02e-06	7.4e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—coronary artery disease	1.01e-06	7.29e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—coronary artery disease	9.86e-07	7.11e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—coronary artery disease	9.66e-07	6.97e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA1—coronary artery disease	9.55e-07	6.89e-06	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AKT1—coronary artery disease	9.45e-07	6.82e-06	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AKT1—coronary artery disease	9.45e-07	6.82e-06	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT1—coronary artery disease	9.45e-07	6.82e-06	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT1—coronary artery disease	9.32e-07	6.73e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—coronary artery disease	8.41e-07	6.07e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—coronary artery disease	8.3e-07	5.99e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—coronary artery disease	7.57e-07	5.46e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—coronary artery disease	7.24e-07	5.22e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—coronary artery disease	6.62e-07	4.78e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.07e-07	2.94e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKT1—coronary artery disease	3.33e-07	2.4e-06	CbGpPWpGaD
